Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667118 · ClinicalTrials.gov registry record · NA
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 705
- Enrollment target
NCT03667118: Completed NA study, sponsored by Northwestern University.
NCT03667118 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 705 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667118, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 705 participants
- Enrollment target
Study Summary
The purpose of the study is to test a food supplement to: * Show that the food supplement is well tolerated and safe to feed to infants; * Find out how often parents/caregivers feed their infants the food supplement; * Find out how parents/caregivers usually add the food supplement to infants' regular solid or liquid food; and * Learn what aspects of the food supplement are more or less attractive to infants and to parents/caregivers.
Primary Outcome
difference between the proportion of infants with allergic-type reaction within 2 hours of ingestion in the food supplement versus placebo arm
Interventions
- DIETARY_SUPPLEMENT Food Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 705 participants |
| Start Date | 2017-06-18 |
| Est. Completion | 2017-10-09 |
| Phase | NA |
What the finished NCT03667118 record still lists
NCT03667118 is an interventional study that assigns participants to a tested intervention. The registered 705 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which Food Supplement is the first listed.
NCT03667118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03667118 about?
NCT03667118 is a clinical study titled "Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals". The purpose of the study is to test a food supplement to: * Show that the food supplement is well tolerated and safe to feed to infants; * Find out how often parents/caregivers feed their infants the food supplement; * Find out how parents/caregivers usually add the food supplement to infants' regu...
What is the current status of trial NCT03667118?
This trial is currently completed. It is a NA study. The enrollment target is 705 participants. The study started on 2017-06-18. Estimated completion is 2017-10-09.
What interventions are being tested in trial NCT03667118?
The interventions under investigation include: Food Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03667118?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03667118's enrollment target sits among peer trials
705 148th of 2000 higher than 1,853 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- NCT07067463 · 705 participants · Phase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI